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De novo mutation plays an important role in autism
spectrum disorders (ASDs). Notably, pathogenic
copy number variants (CNVs) are characterized by
highmutation rates.We hypothesize that hypermuta-
bility is a property of ASD genes andmay also include
nucleotide-substitution hot spots. We investigated
global patterns of germline mutation by whole-
genome sequencing of monozygotic twins concor-
dant for ASD and their parents. Mutation rates varied
widely throughout the genome (by 100-fold) and
could be explained by intrinsic characteristics of
DNA sequence and chromatin structure. Dense clus-
ters of mutations within individual genomes were
attributable to compound mutation or gene conver-
sion. Hypermutability was a characteristic of genes
involved in ASD and other diseases. In addition,
genes impacted by mutations in this study were
associated with ASD in independent exome-
sequencing data sets. Our findings suggest that
regional hypermutation is a significant factor shaping
patterns of genetic variation and disease risk in
humans.CINTRODUCTION
Spontaneous germline mutation plays an important role in
human disease. For severe neurodevelopmental disorders
such as autism spectrum disorders (ASDs), highly penetrant
alleles are under strong negative selection (Uher, 2009). Such
alleles segregate in the population over few generations or can
frequently be observed as de novo mutations (DNMs) in affected
individuals. Thus, in order to understand this aspect of the
genetics of ASD and other human diseases, wemust understand
the mutational processes that give rise to human genetic diver-
sity and the intrinsic and extrinsic forces that shape patterns of
variation in the genome.
Mutation is a random process. However, the probability of
mutation at a given site is not uniform throughout the genome.
Regional mutation rates are subject to a variety of intrinsic
characteristics (Ellegren et al., 2003) and extrinsic factors such
as parental age (Crow, 2000). This is particularly evident for
structural variation (SV). Rates of structural mutation can vary
between 104 and 106 (Lupski, 2007), and there are numerous
examples of hot spots for structural mutation where recurrent
mutations are mediated by nonallelic homologous recombina-
tion (NAHR) between tandem segmental duplications (Lupski,
1998; Malhotra and Sebat, 2012).
Regional rates of nucleotide substitution are also variable
(Ellegren et al., 2003); however, the factors that influenceell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc. 1431
regional mutability are not well understood. In contrast to the SV
hot spots described above that are predominantly driven by
meiotic recombination, nucleotide substitution can occur by
a variety of mechanisms, and the mutation rate is influenced to
a much greater extent by mitotic mechanisms (Crow, 2000).
Comparisons of genomes from the human and chimpanzee
have found evidence that regional mutability is influenced by
G+C content (Chimpanzee Sequencing and Analysis Consor-
tium, 2005; Coulondre et al., 1978), recombination rate (Hardison
et al., 2003; Hellmann et al., 2005; Lercher and Hurst, 2002), and
chromosome-banding patterns (Chimpanzee Sequencing and
Analysis Consortium, 2005). These studies indicate that regional
mutation rates are influenced by various properties of the
genome and that no single factor can explain the observed
patterns of genetic diversity and divergence in humans.
However, previous studies do not represent a complete and
unbiased view of germline mutation. The full extent of variation
in mutation rates genome wide remains unclear (Francino and
Ochman, 1999; Nelis et al., 1996; Webster et al., 2003), and
the relevance of hypermutability to common diseases such as
ASD is not known.
We have investigated global and regional rates of nucleotide
substitution by direct detection of germline mutations in mono-
zygotic (MZ) twins concordant for ASD and their parents. We
show that the distribution of mutations in the genome is
nonrandom. Wide variation in regional mutation rates can be ex-
plained by intrinsic characteristics of the genome. Furthermore,
we find significant evidence that genes impacted by DNMs in
twins are associated with autism in independent cohorts.
RESULTS
Detection of Germline Mutations by Whole-Genome
Sequencing in MZ Twins
We applied a whole-genome sequencing (WGS) strategy to
characterizing patterns of germline mutation (Figure S1 available
online). Central to our approach was the selection of a MZ
twin-family sample and the development of a custom machine-
learning-based method for DNM calling.
Cell line-derived genomic DNAs from ten MZ twin pairs
concordant for ASD and their parents were obtained from
the NIMH genetics initiative biorepository (http://www.
nimhgenetics.org). Concordant MZ twins afford significant
advantages to this study. Disease risk can be more directly
attributed to risk factors in the germline. In addition, having
complete genome sequences on identical twins allows us to
readily distinguish germline mutation from somatic and cell line
mutations. To improve our power to account for paternal age
effects on mutation rate, half of the twin pairs were selected to
have younger fathers (16–29 years old), and half were selected
to have older fathers (38–41 years old).
Deep (403) WGS was performed at BGI using the Illumina
HiSeq platform. Raw sequence files were processed at UCSD
with a WGS pipeline consisting of automated tools for alignment
and variant calling (see Experimental Procedures).
DNM detection was performed using a machine-learning-
based tool as described in Experimental Procedures. Using an
internal ‘‘gold standard’’ set generated by exhaustive validation1432 Cell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc.of putative DNM calls in one quad family (family 74-0352, see
Experimental Procedures), we trained a Random Forest classi-
fier (forestDNM) that discriminates validated DNMs from invali-
dated putative DNMs, based on combinations of the associated
quality metrics. When presented with new sites and quality
metrics, the trained classifier could discriminate true DNMs
from false positives with high sensitivity and low false discovery
rate (FDR). Based on misclassification error on the internal test
set, we estimated that sensitivity was 91% (67 of 74 recovered),
and FDR was 11.8% (9 false positives out of 76 called positives).
Software specifications and validation studies are described in
the Supplemental Information.
We applied forestDNM to the detection of DNMs in quads
and adapted forestDNM further to mutation detection of
DNMs in trios. Mutations that were shared by MZ twins consti-
tute germline mutations. Mutations that were not shared by
MZ twins constitute somatic or cell line mutations (Koren et al.,
2012).
A total of 668 putative germline DNMs were detected
and subject to comprehensive validation studies by Sanger
sequencing and Sequenom genotyping. Validation results on
mother, father, and offspring were obtained for 652 sites, and
incomplete data were obtained for 16 sites (Table S1). DNMs
were confirmed for 565 sites (87%), and 87 DNM calls were inva-
lidated, of which 34 (6%) were false-positive variant calls, and 53
(9%) were true-positive-inherited SNPs falsely called as negative
in one parent. Thus, we confirm the high accuracy of forestDNM
on new data. After excluding invalidated DNMs, subsequent
analyses were performed on the remaining set of 581 DNM calls.
Base composition of DNMs detected in this study was similar
to the base composition of segregating SNPs and DNMs
reported in previous studies by Conrad et al. (2011) and Lynch
(2010) (see Extended Experimental Procedures). In addition,
DNM calls were similar in depth and quality to variant calls for
segregating SNPs (Table S1). Phred-like quality scores and alter-
nate allele counts were slightly higher on average for validated
DNM calls as compared to randomly sampled heterozygous
SNPs (by one additional alternate allele read on average). This
subtle skewing toward higher-quality SNP calls had no effect
on the overall genomic distribution of variants (Extended Exper-
imental Procedures).
Variation in Genome-wide Rates of Germline Mutation
A total of 581 germline DNMswere detected in tenMZ twin pairs.
A mean of 58 DNMs per offspring suggests that the average
genome-wide mutation rate in humans is 1 3 108 per genera-
tion. Our estimate is lower than theoretical estimates by a factor
of two (Haldane, 2004; Kondrashov and Crow, 1993) but consis-
tent with empirical estimates from other WGS studies (Conrad
et al., 2011). Total mutation burden varied between 42 and 75
DNMs per offspring, consistent with previous observations of
mutation rate variation (Conrad et al., 2011). Paternal age
accounted for a substantial proportion of the variability in muta-
tion burden in offspring (p = 0.004; R2 = 0.44; see Figure 1),
whereas maternal age was not significant. To account for any
unforeseen deviations from the assumptions of the Poisson
regression model, we also applied a permutation-based test: the
one-sided p value for the effect of paternal age on mutation rate
Figure 2. Nonrandom Distribution of DNMs in the Genome
Quantile-quantile plots of the observed distribution of inter-DNM distances
within and between individuals and the expected distribution based on
a randommutationmodel. Differences are statistically significant at a = 0.05 by
the KS test. See also Figure S4 and Table S2.
Figure 1. Paternal Age Effect Explains 44% of Variation in Genome-
wide Mutation Rates
Data points represent the total number of autosomal DNMs detected in
offspring. 95% CI, 95% confidence interval. See also Figure S1 and Table S1.was 0.0226. These results allow us to quantify the accumulation
of nucleotide substitutions in spermatogonial cells, which occurs
at an average rate of one new mutation per year. Parent of origin
was determined for 131 DNMs, of which 97 (74%) originated
from the father (Table S1).
Global Patterns of Germline Mutation
Germline DNMs displayed a remarkably nonrandom positioning
in the genome (p = 4.4 3 105, KS test). Compared to a random
mutation model (uniform probability across the assembled
genome; see Experimental Procedures for details), there was
an overrepresentation of DNM pairs spaced more closely than
the expectation (Figure 2). The effect is significant when consid-
ering only the distribution within the individual (intraindividual
DNM spacing) and when considering only the distribution across
individuals (interindividual DNM spacing).
The observed distribution of DNMs reflects the underlying
patterns of mutation and does not reflect nonuniformity in our
ascertainment or validation of DNMs, as mentioned previously
(see Extended Experimental Procedures). As we describe in
the following sections, the distribution of mutations can be ex-
plained by intrinsic characteristics of the genome.
Mutation Clusters
As evident from Figure 2, within individual genomes, we
observed striking enrichment of very closely spaced DNMs
(inter-DNMdistance <100 kb).Where parent of origin information
was known for three loci (chr16:1823255–chr16:1823256,
chr3:90077648–chr3:90077664, chr8:3872643–chr8:3892698),
closely spaced pairs of DNMs had a single parent of origin.
These results are consistent with very closely spaced mutations
arising as part of a single mutation event (Wang et al., 2007)Cwithin a narrow region of a chromosome. Defining a ‘‘cluster’’
as two or more DNMs located within a 100 kb span, a total of
ten mutation clusters were identified on eight chromosomes
(see Table S2), suggesting that mutation clusters occur at
a rate of approximately one per generation. Onemutation cluster
in subject 75-0355 is evident in the 8p23 region illustrated in Fig-
ure 5. The observation of ten dense clusters of DNMs was statis-
tically significant by permutation test (p < 0.001).
Multiple mutational mechanisms could explain these findings,
including compound mutation (Schrider et al., 2011) or gene
conversion (Chen et al., 2007). Nonallelic gene conversion, which
requires the presence of a paralogous sequence variant
elsewhere in the genome, could be ruled out for a majority (eight
of ten) of clusters (see Extended Experimental Procedures).
Clusters could instead be explained by compound mutation or
by de novo nucleotide substitutions that occur during allelic
gene conversion events (Hurles, 2002; Rattray et al., 2002). In
all cases, we could rule out the possibility that mutation clusters
are a spurious observation due to the mismapping of reads
containing a paralogous sequence variant (see Extended Exper-
imental Procedures).
Determining Intrinsic Properties of the Genome that
Influence Mutability
Regional mutation rates are subject to a combination of influ-
ences. In order to investigate the effect of intrinsic properties
of the genome, we used logistic regression to discriminate
DNMs from random genome background sites, based on the
characteristics of the genome at these sites (and not relative or
absolute genomic positions of DNMs). See Extended Experi-
mental Procedures for details on the genomic features used.ell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc. 1433
Figure 3. Individual Associations of Genome Features with DNM
Predisposition to DNM is influenced by sequence and chromatin characteristics. A variety of quantitative genome data was tested for associations with DNM
sites, including conservation, DNase hypersensitivity, GC content, histone marks, lamin B1 association, nucleosome occupancy (occ.), recombination rate,
replication timing, transcription in human embryonic stem cells, simple repeats at the site of DNM, and the particular trinucleotide sequence centered at the site of
DNM. The data were tested for association at different scales (i.e., window sizes at which the genome data were averaged), indicated on the x axis. The strength
and direction of association between the features and DNM are indicated by logistic regression coefficients (y axis), which are shown with their SEs. Significant
associations (FDR <0.10) are indicated in bold type. A summary of the relationship between these features and the PCs used in the predictive model is provided in
Figure S6. A detailed legend of the feature names and their descriptions is provided in Table S6, and further details relating to the origin and construction of the
features can be found in Experimental Procedures.Numerous features were found to influence site mutability. The
most significant features were DNase hypersensitivity, GC
content, nucleosome occupancy, recombination rate, simple
repeats, and the trinucleotide sequence surrounding the site
(Figure 3). We note that the UCSC Dennis and MEC nucleosome
occupancy tracks (Gupta et al., 2008) use scores opposite in
direction to indicate nucleosome occupancy. For both tracks,
nucleosome occupancy was associated with suppressed
mutation.
In addition to testing marginal associations, we investigated
whether interactions between these genome features were
predictive of mutation rate. This was done by performing
two-way ANOVA for all possible combinations of features. After
correcting for multiple testing, no two-way interactions were
significant.
We next sought to construct a predictive model that could
estimate nucleotide level mutation rates, based on information
contained in all the features. This was accomplished by perform-
ing principal components analysis (PCA) on the features and
then using the principal components (PCs) as predictors in
a regularized logistic regression model (again using ‘‘observed
DNM’’ and ‘‘genome background’’ as the class labels). The
output of the model is a measure of mutability that we call the
mutability index (MI). MI is an estimate of relative mutation rate
at single-nucleotide resolution (see Experimental Procedures
for details). Throughout, we use the term ‘‘mutability’’ to refer
to the MI, and we use the term ‘‘mutation rate’’ to refer to the
observed rate of DNMs for a given site or region.1434 Cell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc.Wide Variation in Site-Specific and Regional Mutation
Rates
MI was highly predictive of site-specific (1 bp resolution) muta-
tion rates (Figure 4) and could explain 90% of the variability
inmutation rates at sites across the genome. As expected, muta-
bility was greatest for CpG dinucleotides. However, our model
was highly predictive of mutation rate independent of this
phenomenon. CpG sites and non-CpG sites varied widely in their
mutability (10- and 100-fold, respectively), and the range of CpG
mutability overlapped considerably with the range for non-CpG
sites (Figure S2).
The validity of MI was confirmed in independent data sets of
DNM. MI was highly correlated with mutation rate variation in
a genome-wide data set from two trios (Conrad et al., 2011) (Fig-
ure 4B) and exome data sets from four independent trio-based
studies of autism (Iossifov et al., 2012; Neale et al., 2012;
O’Roak et al., 2011, 2012; Sanders et al., 2012) (Figures 4C
and 4D). In all data sets examined, observed mutation rates
varied consistently by greater than two orders of magnitude
ranging from 108.5 to 106.5. MI explained 90% of variation
of the observed mutation rates in these studies. We conclude
that our statistical model of mutability can explain a majority
of the variance in site-specific mutation rates. Having confirmed
the validity and accuracy of the MI, we apply this measure to the
analysis of regional mutability.
We examined the landscape of mutability throughout
the genome. Mean MI (in nonoverlapping 1 kb windows) re-
vealed broad genomic regions of hypermutability, generally
Figure 4. Intrinsic Characteristics of the
Genome Explain Variation in Observed
Mutation Rates
(A–D) MI at the site level (1 bp) is highly predictive
of the mutation rate in (A) ASD genomes in this
study, (B) control genomes in Conrad et al. (2011),
and in ASD cases (C) and controls (D) of previous
exome studies (combined data from O’Roak et al.,
2011, 2012; Iossifov et al., 2012; Sanders et al.,
2012; Neale et al., 2012). MI explains a majority of
the variability in site-specific mutation rates, and
the degree of mutation rate variation was similar in
cases and controls. CpG sites and non-CpG sites
varied widely in their mutability, and the range of
CpG mutability overlapped considerably with the
range for non-CpG sites (Figure S2). MI was also
predictive of regional mutation rates (Figure S3).tens to hundreds of kilobases in size. These included ‘‘hot
spots’’ with highly elevated mutability (R7-fold) and ‘‘warm
spots’’ with moderately increased mutability (2- to 3-fold)
(Figure 5).
Genomic regions of hypermutability were then defined by
segmenting the MI scores using a five-state hidden Markov
model (HMM). Parameters of the HMM were derived through
numerical optimization by fitting a five component Gaussian
mixture to the overall distribution of mean MI of 1 kb windows
of the genome. The sequence of hidden states along each chro-
mosome was calculated using the Viterbi algorithm. Altogether,
approximately 9% and 0.02% of the genome were defined as
‘‘warm’’ and ‘‘hot,’’ respectively, with 54%, 37%, and 0.5%
being segmented as ‘‘baseline,’’ ‘‘cool,’’ and ‘‘cold.’’
Hypermutability of these genomic regions was confirmed in
this study and in five independent mutation data sets. The
observed rate of DNMs in genomic segments was positively
correlated with the mean MI of segments (Figures S3A
and S3B). Likewise, exonicmutation rates were highly correlated
with the mean MI of exons (Figures S3C and S3D).
These results confirm that the landscape of mutability, like
other characteristics of the genome, is highly nonrandom, in
part explaining the distribution of DNMs that we originally
observed. When we sampled a null model such that representa-
tion of sites was consistent with predicted mutability, the
observed inter-DNM distances were closer to this null distribu-
tion (Figure S4).Cell 151, 1431–1442, DeConsidering that our statistical model
was developed based on a data set of
genomes largely derived from individuals
diagnosed with ASD, we examined
whether the mutation rate variation we
observe is related to autism. We com-
pared the predictive value of MI in cases
and controls in the exome data sets. MI
was equivalently predictive of mutation
rate in healthy individuals (R2 = 0.91,
slope = 0.78) and in ASD cases (R2 =
0.90, slope = 0.79) (Figures 4C and 4D).
Likewise, we compared the total burdenof DNMs in hypermutable genes (average exonic log10
MI >0.5), in cases and controls and observed no association
with ASD (OR = 0.73; p = 0.227). Therefore, the mutation rate
variation that we observe cannot be attributable only to a subset
of disease-associated mutations that is present in autism
genomes.
A U-Shaped Relationship between Genome Mutability
and Evolutionary Conservation
We examined the relationship between regional rates of muta-
tion, evolutionary change and genetic diversity in the human
genome. Our results confirm that some hot spots have under-
gone rapid evolutionary change, consistent with previous
studies by the Chimpanzee Sequencing and Analysis Consor-
tium (2005). However, patterns of germline mutation, particularly
within the exome, reveal many highly mutable regions that
change little over evolutionary time, an observation that chal-
lenges the common definition of the ‘‘evolutionary hot spot.’’
A plot of mutability, divergence, and diversity reveals
a distinctly U-shaped relationship between mutability and
sequence conservation (Figure 6A). In regions that are less
conserved (the left arm of the ‘‘U’’), there is a clear correlation
of hypermutability, hyperdivergence, and hyperdiversity, consis-
tent with such regions undergoing rapid evolutionary change.
Surprisingly, in highly conserved regions (the right arm of the
‘‘U’’), the opposite trend is evident: hypermutability is correlated
with highly conserved sequence and low genetic diversity.cember 21, 2012 ª2012 Elsevier Inc. 1435
Figure 5. Landscape of Mutability in the Genome
(A) The 1 kb average MI across a 20 Mb genomic region of chromosome 8p21-23 indicates the existence of extended regions of hypermutability. ‘‘Hot spots’’
(red), ‘‘warm spots’’ (orange), as well as ‘‘cold spots’’ were defined by segmenting the MI scores using a five-state HMM (see Table S7). Predicted mutation rates
(y axis) were computed by multiplying the arithmetic mean MI by the baseline mutation rate of 108, then transforming to the log10 scale. The genome- and
(legend continued on next page)
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Figure 6. U-Shaped Relationship of Mutability and Evolutionary Conservation
(A) Throughout the genome, we observe a correlation of hypermutability, hyperdivergence, and hyperdiversity, consistent with previous studies. By contrast, in
highly conserved regions, the opposite trend is evident. MI and conservation were averaged in 1 kbwindows genomewide.Windowswere then binned according
to percentiles of conservation.
(B) Specifically within exons, there is a strong positive correlation of mutability and evolutionary conservation (also binned by percentiles of conservation).
(C) The positive correlation betweenmutation rate and average exon conservation was confirmed by data from exome studies. Note that the positive relationship
exists for both cases and controls. Under the null hypothesis, in which exons are hit with probability proportional to their length, this relationship is not observed.We performed a similar analysis of exons and confirmed
a strong positive correlation between MI and conservation (Fig-
ure 6B). However, the right arm of the ‘‘U’’ (Figure 6A) could not
be entirely explained by exonic sequences. We repeated the
analysis in Figure 6A after excluding all exons, and the same
U-shaped relationship was observed (data not shown). Finally,
we confirmed a positive correlation of conservation andmutation
rate in protein-coding exons in exome data sets of ASD (Fig-
ure 6C). Notably, the positive correlation between mutation
rate and conservation was similar in cases and in controls.
Therefore, this trend does not appear to reflect patterns that
are unique to mutations that are detected in subjects with
ASD. The aforementioned results suggest that mutability in the
genome is, to some extent, coupled with functionality.
There are multiple genomic features that vary with evolu-
tionary conservation in a similar fashion, most notably GC
content. However, this feature alone does not explain patterns
of mutability (see Figure 3). Importantly, genotype quality of
SNPs and DNMs was not correlated with conservation (data
not shown); hence, these observations do not appear to be an
artifact of variable ascertainment.
Hypermutability Is Common among Disease Genes
Genes that are subject to high mutation rates and strong puri-
fying selection could be of particular importance to human
disease. Mutability was significantly elevated for essential genes
derived from the Online GEne Essentiality (OGEE) database
(Chen et al., 2012) and human disease genes derived from the
Online Mendelian Inheritance in Man (OMIM) database and
varied by the modes of inheritance (Figures 7A and 7B). Muta-
bility was highest for essential genes and genes associated
with dominant disorders. Mutability was elevated to a lesser
extent for genes involved in recessive or polygenic traits.exome-wide distributions of MI are depicted in Figure S7. The locations of DNMs
(red, DNMs <100 kb apart marked by asterisk).
(B) The lower panel displays segmentation results for a second genomic region a
mutation. In the same region, the predicted rate of nucleotide substitutions is hig
COf relevance to our disease of interest, mutability of genes
preferentially expressed in the brain was significantly higher
on average. In addition, mutability was elevated in a litera-
ture-based set of genes that have been implicated in ASD
and in a set of genes that are associated with ‘‘syndromic’’
forms of autism (Figures 7C and 7D). Examples of hypermu-
table ASD-associated genes include NRXN1, AUTS2,
GABRB3, SHANK2, and KCNMA1, which have one or more
exons that rank among the top 20% most highly mutable in
the exome (Tables S3 and S4). Another particularly striking
example of a disease-associated hot spot (see Figure 5B) is
the 15q11-13 region. This region is well known for having an
elevated structural mutation rate due to its local segmental
duplication architecture, where recurrent duplications are
associated with ASD, and deletions are associated with Prader
Willi/Angelman syndrome (Ledbetter et al., 1981). As we
observe here, mutability of the DNA sequence within 15q11-
13 is also predicted to be highly independent of the local dupli-
cation architecture, suggesting that rates of nucleotide substi-
tution are also elevated in this region.
Exonic Mutations in MZ Twins Are Significantly
Associated with ASD
DNMs detected in our MZ twin samples impacted a total of 34
genes (Table S1), including 29 protein-coding genes and 5
noncoding RNAs. We hypothesize that genetic risk in our patient
population is explained in part by DNMs in some of the afore-
mentioned genes. We investigated the frequency of DNMs in
protein-coding genes in larger exome data sets on 962 cases
and 590 controls from recent studies of ASD (1,035 mutations
in 969 genes in cases, 564 mutations in 536 genes in controls)
(Iossifov et al., 2012; Neale et al., 2012; O’Roak et al., 2011,
2012; Sanders et al., 2012).are also shown and include a dense cluster of DNMs from individual 74-0355
t 15q11-13. This region is notable for having a high rate of recurrent structural
hly elevated.
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Figure 7. Disease Genes Are Characterized
by High Mutability
(A–D) Disease genes are more mutable than non-
disease genes (A) within genes and (B) within
exons. In both cases, mutability is highest for
genes involved in dominant disorders, and muta-
bility is increased to a lesser extent for genes
involved in recessive and polygenic traits. Muta-
bility is significantly elevated for genes preferen-
tially expressed in the brain (C and D) as well as
genes involved in ASD (see Experimental Proce-
dures for details). An asterisk indicates a signifi-
cant difference compared to the respective
background set (at a = 0.01 by a two-sided t test).
See also Tables S3 and S4 for the mean MI of
exons and genes, respectively.In our set of 29 genes, zero exonic hits were reported in
controls, consistent with the low probability of observing an
overlapping gene by chance. By contrast, seven de novo-coding
mutations of five genes were detected in cases, and two genes
(KIRREL3 and GPR98) were hit twice. This constitutes a signifi-
cant genetic overlap between genes mutated in concordant
MZ twins and sporadic ASD cases for total number of hits (p =
0.006), number of double hits (p = 0.005), and number of genes
(p = 0.04). See Extended Experimental Procedures for details on
the calculation of these empirical p values.
DISCUSSION
Our model of intrinsic mutability, based on the unbiased ascer-
tainment of germline mutations in families, reveals wide variation
in mutation rates throughout the genome. The results of our
study provide a global view of this landscape of mutability and
its corresponding influence on genetic diversity and suscepti-
bility to disease in humans. We show that hypermutability is
a characteristic of disease genes, including genes that have
been implicated in autism.
Mutability is explained by multiple influences acting in combi-
nation. For instance, a specific di- or trinucleotide motif may
have an elevated mutation rate. However, mutability of the site
can be further modulated by other factors, including factors
acting on larger scales such as nucleosome occupancy
(102 bp), recombination rate (104 bp), and replication timing
(106 bp). Mutation rate variation in somatic cells (Koren et al.,
2012) and cancer (Schuster-Bo¨ckler and Lehner, 2012) is also
influenced by aspects of chromatin structure, consistent with
partially overlappingmutational mechanisms acting in germ cells
and somatic cells.
The patterns of mutability that we have uncovered provide
new insights into the relationship between mutation, genetic
diversity and disease that were not evident from studies of
segregating genetic variation (Ellegren et al., 2003). We demon-1438 Cell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc.strate that genome mutability and evolu-
tionary conservation have a U-shaped
relationship. Paradoxically, some of the
mostly highly mutable sequences in the
genome are in fact highly conserved.The correlation of hypermutability and high evolutionary
conservation is surprising and could not have been predicted
from previous studies based on segregating variation in humans.
We consider three possible theories to explain this finding. The
first is the hypothesis that regional hypermutability itself is a trait
that could be selected for under certain conditions, for instance,
where greater genetic diversity at a specific locus provides
a fitness advantage. This hypothesis is reminiscent of the classic
concept of ‘‘adaptive mutation’’ (Delbru¨ck and Bailey, 1946;
Rosenberg, 2001), a process by which genome-wide mutation
rates in bacteria increase in response to selective pressure.
The second is the hypothesis that certain functional and highly
conserved elements originated from ancient mutation hot spots
and have since been subject to intense purifying selection. The
third is the hypothesis that conserved hot spots could be ex-
plained simply by the fact that some DNA repair mechanisms
are coupled with gene regulation (van Attikum and Gasser,
2005) or transcription (Svejstrup, 2002). Thus, the most highly
transcribed regions in a given tissue could be the most suscep-
tible to mutation. Further studies are needed to determine the
underlying mutational and evolutionary mechanisms, but these
findings have a significant implication regardless: patterns of
mutation in the human genome appear to favor genetic changes
that influence biological function.
Hypermutability in the genome has implications for human
disease. Mutability is highest for essential genes and genes
involved in dominant disorders. To a lesser extent, mutability is
elevated for genes primarily involved in recessive disorders or
polygenic traits (polygenes). Likewise, hypermutable loci are
likely to be important in neurodevelopmental disorders. Muta-
bility was significantly elevated for a large set of genes that are
preferentially expressed in the brain and genes that have been
implicated in ASD. Our results are consistent with a prominent
role for recurrent DNMs in autism and in other traits that have
a contribution from dominant-acting alleles. We view these
results, and the previous observation that mutation occurs at
higher rates in highly conserved elements, as possibly two sides
of the same coin. Presumably, the selective pressures that
constrain evolutionary divergence and nucleotide diversity in
mutational hot spots are acting upon disease phenotypes such
as ASD.
The genome-wide rate of mutation in individuals with ASDwas
not high. The averagemutation rate in the genomes of patients in
this study was 1 3 108. While the present study was under
review, three studies were published using WGS to estimate
the human mutation rate. These studies yielded estimates in
the same range as ours (0.89–2.3 3 108) (Campbell et al.,
2012; Kong et al., 2012; Sun et al., 2012). Also, one study docu-
mented the occurrence of compound mutations and gene
conversion events (Campbell et al., 2012). A second study also
documented a paternal age effect on germline mutation rates
(Kong et al., 2012). Collectively, these studies suggest that the
true mutation rate in humans is lower than previous theoretical
estimates by Haldane (2004), Kondrashov and Crow (1993),
and Nachman and Crowell (2000), possibly by as much as
a factor of two. This knowledge has led some to consider a reca-
libration of the timescales of human evolution and the divergence
of human populations (Scally and Durbin, 2012). These results
also suggest that, after accounting for any effects due to paternal
age, genome-wide rate of mutation in most individuals with
autism is not significantly elevated.
The mutation rate variation that we observed in this study
reflects patterns of mutation in a sample of subjects with ASD.
This fact raises the possibility that disease mutations in our
data set could have an influence on the overall distribution of
DNMs and estimates of site-specific mutability. When we
compared mutation rates in exomes of cases and controls, we
did not find evidence that mutation rate variation differs between
affected and unaffected individuals. However, due to a paucity of
available genome-wide data on controls, we are not able to
compare regional mutation rates of intronic and intergenic
regions in cases and controls. Thus, we cannot rule out the
possibility that the distribution of DNMs in individuals with ASD
might tend to exhibit a higher level of clustering around disease
genes.
The set of genes impacted by DNMs in concordant MZ twins
demonstrated a significant association with autism in indepen-
dent samples, a result that was equally surprising and tantalizing.
Given that the majority of exonic DNMs in autism cohorts are
likely to be unrelated to disease (Neale et al., 2012; Sanders
et al., 2012), we anticipated the same to be true for DNMs in
our MZ twin pairs. To the contrary, a set of independent
exome-sequencing studies (962 cases and 590 controls) de-
tected seven exonic mutations in five genes exclusively in cases,
a result that is unlikely to occur by chance. This result suggests
that exonic mutations in our MZ twin sample may be enriched in
causal variants as compared to DNMs in the more typical
sporadic/simplex cases.
These results do not provide conclusive evidence implicating
individual genes in autism. However, mutations detected in our
concordant twin sample and in independent studies highlight
some intriguing candidates. These includeGPR98 andKIRREL3,
where three de novo pointmutations of each have been detected
exclusively in cases, and a balanced translocation disruptingCKIRREL3 has been reported in a recent study by Talkowski
et al. (2011). In addition, the TCF4 gene is a strong candidate
given the documented involvement of this gene in Pitt Hopkins
syndrome (Amiel et al., 2007; Zweier et al., 2007) and intellectual
disability (Hamdan et al., 2012; Need et al., 2012), and the obser-
vation ofmultiple DNMs of TCF4 in ASD (this study; O’Roak et al.,
2012).
As exemplified by early success from the preceding waves of
copy number variant (CNV) (Sebat et al., 2007) and exome-
sequencing (Iossifov et al., 2012; Neale et al., 2012; O’Roak
et al., 2012; Sanders et al., 2012) studies in ASD, new technolo-
gies for detection of mutations in the genome hold promise for
understanding the genetic basis of this disorder. WGS provides
another major boost to our ability to ascertain point mutations
and CNVs (Michaelson and Sebat, 2012). This considerable
improvement in mutation discovery comes at a relatively modest
increase in sequencing cost. As the field continues its rapid tran-
sition toward incorporating comprehensive data on genomic
variation and DNMs into genetic studies, we anticipate progress
toward a deeper understanding of the underlyingmechanisms of
genome evolution and disease.EXPERIMENTAL PROCEDURES
WGS
Genomic DNAs from ten identical twin pairs and their parents were obtained
from the NIMH genetics initiative biorepository (http://www.nimhgenetics.
org). All DNA samples were derived from EBV-immortalized lymphoblastoid
cell lines. A list of the 40 samples is provided in the Extended Experimental
Procedures. Deep (403) WGS was performed at BGI using the Illumina HiSeq
Platform (500 bp library, 90 bp reads). Prior to sequencing, samples were
randomized to minimize batch effects. Genomes were aligned to hg18 with
BWA (Li and Durbin, 2009), and all subsequent analyses were performed
with hg18 as the reference unless otherwise stated.Alignment and Variant Calling
Alignment and variant (SNP) calls were generated on quad families using our
WGS analysis pipeline implemented on the Triton compute cluster at UCSD
(http://tritonresource.sdsc.edu/). Short reads were mapped to hg18 reference
genome by BWA version 0.59 with the following parameters: ‘‘aln -o 1 -e 63 -i
15 -I -l 31 -k 2 -t 6.’’ Subsequent processing was carried out using SAMtools
version 0.18, GATK version 1.2-52 (DePristo et al., 2011), and Picard tools
version 1.52, which consisted of the following steps: sorting and merging of
the BAM files, indel realignment, fixing mate pairs, removal of duplicate reads,
base quality score recalibration for each individual. Variant calls for each family
were made (in ‘‘trio’’ mode) by running the unified genotyper for all four family
members.DNM Detection
Based on experience from our earlier CNV-based studies of DNM (Malhotra
et al., 2011; Nord et al., 2011; Sebat et al., 2007), an unfiltered set of putative
DNMs is highly enriched for errors. In order to accurately distinguish true de
novo variants from errors, we employed a custom machine-learning pipeline
we call forestDNM. A detailed description of the development and validation
of this software is provided in Extended Experimental Procedures. Briefly,
a Random Forest (RF) classifier was trained using quality metrics (see Table
S5) on an initial set of positive and negative training examples obtained by
comprehensive validation of unfiltered putative DNMs from a single family
(family 74-0352). See Figure S5 for a depiction of the predictive importance
of each quality metric. The trained classifier had an estimated sensitivity of
91% (67 of 74 recovered) and an estimated specificity of 11.8% (9 false posi-
tives out of 76 called positives). We used this trained RF classifier to predict theell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc. 1439
validation status of the putative DNMs in all families. In total, we predicted 668
DNMs in the ten families.
Experimental Validation
Putative DNMs were validated by genotyping offspring using two indepen-
dent validation methods: Sanger sequencing and Sequenom MassArray
genotyping technologies (see Extended Experimental Procedures). Parental
genotypes were obtained using the Sequenom platform and additionally by
Sanger sequencing if an informative Sequenom assay could not be
designed. A total of 565 of 668 putative DNMs sites were validated, and
87 sites were invalidated (34 as false heterozygous calls in the twins, 53 as
inherited variants), corresponding to an overall observed FDR of 13%. In
all subsequent analyses, we combine sites with complete validation data
(565) with sites with incomplete validation data (16) for a total of 581
DNMs. Given the demonstrated low FDR of the classifier, we only expect
2 of the 16 incompletely validated sites to be false positives, so their inclu-
sion is justifiable.
Parental Age Effect
We used Poisson regression to test the relationship between paternal and
maternal age and DNM burden (Figure 1; Table S1). In a fit using both paternal
and maternal age as covariates, paternal age was significant (p = 0.01), but
maternal age was not (p = 0.6). We thus discardedmaternal age and fit amodel
using only paternal age, which had a significant effect (p = 0.0039) and a slope
of approximately one DNM/year.
Analysis of the Effect of DNA and Chromatin Features on DNM
We investigated whether quantitative genomic features (see Extended Exper-
imental Procedures for details on training data and features) had individual
associations to DNM by fitting logistic regression models (classes: observed
DNM or genome background site), using each of the genome features as
covariates. The coefficients and their SEs are shown in Figure 3, and those
features with significant (FDR <0.10) associations have been noted in bold-
faced type. Positive coefficients indicate a positive association between the
value of the feature and DNM as the predicted class, whereas negative
coefficients indicate a negative association.
Modeling Intrinsic Mutability of the Genome
With an unbiased set of germline mutations as training data, we used regular-
ized logistic regression to predict mutability of sites based on intrinsic charac-
teristics of the genome (see Extended Experimental Procedures for details).
We assembled quantitative genome features (conservation, transcription,
GC content, simple repeat entropy, replication timing, recombination rate,
DNase hypersensitivity, histone marks, nucleosome occupancy, lamin B1
association) and summarized them at several scales by taking the mean value
in windows of 10 bp, 100 bp, 1 kb, 10 kb, 100 kb, 1 Mb, and 10Mb. The bulk of
these data was derived from UCSC Genome Browser tracks (http://genome.
ucsc.edu), and their provenance is outlined in detail in Table S6. In addition
to these features, we included a numerical variable that indicated predisposi-
tion to DNM, based on the trinucleotide sequence centered at the site (see
Extended Experimental Procedures for details).
Using these genomic features directly in the model would be problematic
because they are highly correlated, with large-scale variation in GC content
being one major source of the correlations. In order to more fully exploit the
information carried in the features, we performed PCA, to produce 78 decor-
related features (i.e., the PCs).
PCs represent the unique signals in the data and were used in place of the
genome features as predictors in the model. Using these, we fit the model to
the training data and defined a linear relationship between the class member-
ship probability and the logarithm of the fold DNM excess at that probability.
The relationship among genomic features, the PCs, and themodel coefficients
is shown in Figure S6. We define the MI as the log10 of the fold excess of
training set DNMs observed for a given predicted class probability. This fold
excess is an estimate of relative mutation rate. Using the model, we deter-
mined MI for every position in the genome. The genome and exome-wide
distribution of MI at the single-nucleotide level is given in Figure S7.1440 Cell 151, 1431–1442, December 21, 2012 ª2012 Elsevier Inc.To define regional patterns of mutability, we segmented the genome-wide
map of mutability with a five-state (cold, cool, baseline, warm, hot) HMM
(see Table S7). In all analyses involving exons, the exon boundaries were
used to define regions, and the mean MI over the exon was used as the repre-
sentative mutability.
Genomic Distribution of DNMs
We computed two types of inter-DNM distance, considering first the nearest
neighboring DNM within an offspring (i.e., a twin pair) and then the nearest
neighboring DNM in another unrelated offspring. We call these the within-
individual inter-DNM distance and the between-individuals inter-DNM
distance, respectively. We then computed null distributions by sampling
random positions from the genome (excluding assembly gaps) while main-
taining the number and family-wise allocation per chromosome of DNMs,
then calculating both inter-DNM distances as described. Using the KS test,
we found that both observed distributions were significantly enriched (at
a = 0.05) for smaller inter-DNM distances compared to the simulated null
distributions (Figure 2), suggesting that observed DNMs are spaced more
closely than expected by chance.
In light of our exploration of genome-wide mutability, we hypothesized that if
the null distributions were sampled such that a site’s probability of inclusion in
the sample was proportional to its MI, the deviation of the observed inter-DNM
distance distribution from the expectation would be attenuated. This was
indeed the case for both inter-DNM distance measures (Figure S4), as shown
by the difference in p values where both uniform sampling and weighted
(i.e., by MI) sampling were used to construct the null distributions.
Correlation of MI with Mutation rate
Site-Level Analysis
The genome was binned with respect to nucleotide-resolution MI in incre-
ments of 0.1 on the log10 scale, and both the proportion of the genome scored
within that bin, as well as the diploid mutation rate of sites scored within that
bin, were calculated. We used sites from this work, Conrad et al. (2011),
Iossifov et al. (2012), Neale et al. (2012), O’Roak et al. (2011, 2012), and
Sanders et al. (2012), which were lifted over from hg19 to hg18 coordinates,
in the calculation of these mutation rates (Figure 4).
Regional Analysis
We examined whether the trend of increasing mutation rate with increasing MI
also heldwhen looking at a regional scale. ForWGS studies (this study; Conrad
et al., 2011), we used the previously described HMM segments, with their
mean MI as the representation of regional mutability. We then binned such
that each bin contained an equivalent number of DNMs (10%) and then calcu-
lated the diploid mutation rate (Figures S3A and S3B). For exome studies
(Figures S3C–S3F), we used the mean MI of exons as the measure of regional
mutability, again binned the exons such that each bin contained 10% of DNMs
from the respective study, and finally calculated the diploid mutation rate.
Linear regressionmodels were fit for each study independently, and all studies
showed a positive correlation between MI and mutation rate (all slopes were
significant at a = 0.01 except Conrad et al., 2011, which had the fewest DNMs).
Conservation, Segregating Variation, and Mutability
We investigated the relationship among MI, segregating variation, and evolu-
tionaryconservation (Figure6)byfirst binning regions (genomicHMMsegments
and exons) according to the percentiles of their mean conservation values
(yielding 100 bins). We then calculated the bin’s mean MI, mean conservation,
and SNP density. SNPs were compiled from the families in this study, and the
total number of observed SNPs was counted per bin, rather than the number
of polymorphic sites (this places more emphasis on common variation).
Mutability and the Genetic Mode of Disease Genes
We compared trends in mutability when classifying genes according to the
genetic basis of their related disease phenotype (Figures 7A and 7B). For poly-
genic disease traits, we consulted the NHGRI GWAS catalog (Hindorff et al.,
2009) and selected the most commonly studied diseases: diabetes (types I
and II), coronary heart disease, Crohn’s disease, ulcerative colitis, mul-
tiple sclerosis, and rheumatoid arthritis. We selected genes that had a SNP
(i.e., within its boundaries) referenced in the GWAS catalog and classified
them as ‘‘polygene’’ (296 genes). For the recessive and dominant categories,
we downloaded the OMIM database (http://omim.org) and extracted genes
that were connected to diseases with ‘‘recessive’’ and ‘‘dominant’’ in the title,
respectively (122 and 86 genes). Essential genes were extracted from the
OGEE database (Chen et al., 2012) for a total of 1,394 genes. Together, these
sets of genes comprised our ‘‘disease genes,’’ and all remaining genes were
considered as the background set. We computed gene and exon mean MI
for all genes and compared trends in mutability by performing a t test on
each category, with the ‘‘background’’ set of genes as the reference group.
To show the trends of enriched mutability in each category, we calculated
a bootstrapped group mean. This was accomplished by bootstrap sampling
equal numbers (100 and 1,000 for genes and exons, respectively) from the
category under consideration (background, polygene, recessive, dominant,
or essential) and computing the mean of each sample. This was performed
1,000 times for each group.
Mutability of Brain and Autism Genes
An approach similar to that described above was used for investigating the
trend of mutability in brain and autism genes, compared to the background
set of all other genes (Figures 7C and 7D). A list of genes preferentially ex-
pressed in the brain was assembled (totaling 2,577) according to the approach
used in Raychaudhuri et al. (2010). We also assembled two sets of autism
genes. The first was an inclusive set of ASD genes based on the strength of
their connection to autism in the literature. This was accomplished by using
NCBI mappings between Entrez gene IDs and PubMed IDs together with
Fisher’s exact test to find genes significantly associated with autism publica-
tions. We thresholded the list at FDR <0.01, resulting in 93 literature-supported
genes that have been implicated in ASD. The second was a partially overlap-
ping set that included only ‘‘syndromic-ASD’’ genes (CACNA1C, CNTNAP2,
FMR1, MECP2, NLGN3, NLGN4X, PTEN, SHANK3, TSC1, TSC2, and
UBE3A) and ‘‘ASD-related’’ genes (AGTR2, ARX, ATRX, CDKL5, FOXP2,
HOXA1, NF1, and SLC6A8) from a previous study by Sakai et al. (2011). We
added to this list three additional syndromic ASD genes, including KCNMA1
(Laumonnier et al., 2006), AUTS2 (Huang et al., 2010), and SHANK2 (Berkel
et al., 2010). Again, we used t tests and bootstrapped means to compare
the distributions of brain and autism-implicated genes against the background
set of all other genes.
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